{
    "id": 32853,
    "fullName": "CIC over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CIC over exp indicates an over expression of the Cic protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 23152,
        "geneSymbol": "CIC",
        "terms": [
            "CIC",
            "MRD45"
        ]
    },
    "variant": "over exp",
    "createDate": "03/21/2020",
    "updateDate": "03/21/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 21066,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, high pre-treatment Cic expression level correlated with superior overall survival (p=0.021) in patients with hepatocellular carcinoma compared to patients with low Cic expression (PMID: 32169577).",
            "molecularProfile": {
                "id": 35526,
                "profileName": "CIC over exp"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 684,
                "name": "hepatocellular carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 18320,
                    "pubMedId": 32169577,
                    "title": "Inactivation of transcriptional repressor Capicua confers sorafenib-resistance in human hepatocellular carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/32169577"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35526,
            "profileName": "CIC over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}